{"id":11390,"date":"2011-09-15T00:00:00","date_gmt":"2011-09-14T22:00:00","guid":{"rendered":"https:\/\/idibell.cat\/es\/blog\/2011\/09\/15\/el-idibell-reune-expertos-de-primer-nivel-en-bioinformatica-biologia-de-sistemas-y-regulacion-genomica\/"},"modified":"2020-05-26T10:00:32","modified_gmt":"2020-05-26T08:00:32","slug":"el-idibell-reune-expertos-de-primer-nivel-en-bioinformatica-biologia-de-sistemas-y-regulacion-genomica","status":"publish","type":"post","link":"https:\/\/idibell.cat\/es\/2011\/09\/el-idibell-reune-expertos-de-primer-nivel-en-bioinformatica-biologia-de-sistemas-y-regulacion-genomica\/","title":{"rendered":"El IDIBELL reune expertos de primer nivel en Bioinform\u00e1tica, Biolog\u00eda de Sistemas y Regulaci\u00f3n Gen\u00f3mica"},"content":{"rendered":"
Destacados expertos en bioinform\u00e1tica, biolog\u00eda de sistemas y regulaci\u00f3n gen\u00f3mica procedentes de todo el mundo se reunir\u00e1n del 14 al 19 de octubre en el IDIBELL para hablar sobre los \u00faltimos avances en estos campos.<\/strong> Los congresos son una oportunidad para conocer los \u00faltimos hallazgos en biolog\u00eda celular, gen\u00e9tica molecular, regulaci\u00f3n gen\u00f3mica y biolog\u00eda de sistemas, as\u00ed como para establecer nuevas colaboraciones para mejorar la comprensi\u00f3n de los fundamentos de la vida y los procesos que dan lugar a la aparici\u00f3n de enfermedades, especialmente el c\u00e1ncer.<\/p>\n Los simposios cuentan con la participaci\u00f3n de expertos internacionales de primer nivel.<\/p>\n DREAM ENGINEERING CHALLENGES RICCI CONFERENCE ON CANCER INFORMATICS RECOMB SYSTEMS Biology Destacados expertos en bioinform\u00e1tica, biolog\u00eda de sistemas y regulaci\u00f3n gen\u00f3mica procedentes de todo el mundo se reunir\u00e1n del 14 al 19 de octubre en el IDIBELL para hablar sobre los \u00faltimos avances en estos campos. DREAM ENGINEERING CHALLENGES Presidente: Gustavo Stolovitzky RICCI CONFERENCE ON CANCER INFORMATICS Presidente: Miguel Angel Pujana RECOMB SYSTEMS Biology Presidente: Andrea Califano RECOMB REGULATORY GENOMICS Presidente: Manolis Kells<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[286],"tags":[],"class_list":["post-11390","post","type-post","status-publish","format-standard","hentry","category-epigenetica-del-cancer-cancer"],"publishpress_future_action":{"enabled":false,"date":"2024-09-14 15:20:55","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/11390"}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=11390"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/11390\/revisions"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=11390"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/categories?post=11390"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/tags?post=11390"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Esta es la primera vez que se celebran fuera de los Estados Unidos los congresos DREAM (siglas de Dialogue for Reverse Engineering Assessments and Methods) y RECOMB (Research in Computational Molecular Biology), a los que se ha a\u00f1adido la Conferencia IDIBELL sobre bioinform\u00e1tica RICCI (Research, Computational Biology and Cancer Informatics). Las sesiones tendr\u00e1n lugar en el hotel Hesperia de L’Hospitalet de Llobregat.<\/p>\n
Presidente: Gustavo Stolovitzky<\/strong>
Ewan Birney. European Bioinformatics Institute.
Edda Klipp. University of Berlin.<\/p>\n
Presidente: Miguel Angel Pujana<\/strong>
Raymond Cho. University of California at San Francisco.
Manel Esteller. IDIBELL.
N\u00faria L\u00f3pez Bigas. Universidad Pompeu Fabra.
Franziska Michor. Dana Farber Cancer Institute.
Dana Pe’er. Columbia University.
Julio S\u00e1ez Rodr\u00edguez. European Bioinformatics Institute.
Gustavo Stolovitzky. IBM.
Alfonso Valencia. Spanish National Cancer Research Centre.<\/p>\n
Presidente: Andrea Califano<\/strong>
Scott Armstrong. Harvard.
Barry Honig. Columbia University.
Manolis Kells. MIT \/ Broad.
Rune Linding. Center for Biological Sequence Analysis.
Sylvia Plevritis. Stanford.
Luis Serrano. Center for Genomic Regulation.
Dennis Vitkup. Columbia University.
RECOMB REGULATORY GENOMICS
Presidente: Manolis Kells<\/strong>
Martha L. Bulyk. Harvard Medical School.
Andrea Califano. Columbia University.
Eileen Furlong. EMBL
Jonathan Pritchard. University of Chicago.
Alexander Stark. IMP Viena.<\/p>\n","protected":false},"excerpt":{"rendered":"